What's NEW for the 2018 Aseptic Conference

  • Containment, Highly Potent/Toxic Aseptic Track
    • Toxic processing, industrial hygiene, modular aseptic and manufacturing of Antibody-drug conjugates (ADCs).
    • Breakout discussion session
  • Sterility Assurance for End to End Manufacturing Process
  • Highly Potent Antibody-drug conjugates (ADCs)
  • Using new technology with a focus on patient and product safety
  • Creating a vision to upgrade legacy facilities
  • Robotics - mitigate traditional fill line challenges and enhance product safety

The Evolution of Aseptic Processing Continues: From Barriers to Disposables

Now in its 27th year, ISPE’s 2018 Annual Aseptic Conference remains at the forefront of education in the evolution of aseptic technology, providing information designed to help manufacturers deliver safe and reliable product supply while ensuring patient safety. The conference educates pharmaceutical manufacturing professionals in the field about the latest technologies related to Aseptic Processing. This year’s focus on robotics, sterility assurance, disposables, upgrading legacy facilities, and a new half-day track on highly potent and toxic products, provides a topic of interest for everyone.

Enjoying longstanding support and engagement of FDA regulators, this year’s conference hosts several regulatory experts and provides participants with key regulatory insights and dialogue. Robert Sausville, Director, Division Case Management, FDA/CBER/OCBQ/DCM opens the conference with the keynote session. He also moderates a regulatory panel discussion on the second day.

Content-rich sessions led by renowned experts introduce new technological achievements in the fields of aseptic fill-finish operations such as robotics, sophisticated dispensing systems, and disposables. Case study presentations about successfully employed innovative and aseptic industry best practices provide practical solutions for the growing complexities of aseptic processing without losing focus on classic Aseptic and Barrier applications.

In addition to case studies, six manufacturing companies present their experience with and benefits of using robotics in aseptic processing during an industry panel discussion on the first day of the conference.

On the second day, the Keynote session features Joyce Hansen, Vice President, J&J Sterility Assurance, Johnson & Johnson speaking about becoming change agents in creating a vision for legacy facilities upgrades.

Following the education sessions on day two of the conference, participants engage in interactive break-out sessions and discussions

Program Committee Members:

Jorg Zimmermann

Jörg Zimmermann
Vice President/Bereichsleiter Vetter Development Service
Vetter Pharma-Fertigung GmbH & Co. KG, Germany


Hite Baker

Hite Baker
Principal Process Engineer

Michael Faia

Michael Faia
Associate Director
Project Management
Jazz Pharmaceuticals, Inc.



Klaus Ullherr

Klaus Ullherr
Senior Product Manager
Robert Bosch Packaging Technology GmbH

Matthew Von Esch

Matthew VonEsch
Senior Director of Manufacturing and Facilities

Richard Denk

Richard Denk
Director Sales Containment